Form 4: Aptevo Therapeutics Director Grant Grady III Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Director Grant Grady III reports acquisition of Aptevo Therapeutics common stock through the vesting of restricted stock units.

Summary

  • On June 1, 2024, Director Grant Grady III acquired 7 shares of Aptevo Therapeutics common stock through the vesting of restricted stock units (RSUs).
  • On June 2, 2024, Grady acquired 81 shares of common stock through the vesting of additional RSUs.
  • The RSUs convert into common stock on a one-for-one basis.
  • The reported amounts have been adjusted to reflect a 1-for-44 reverse stock split that occurred on March 5, 2024.
  • The director now directly owns 117 shares of common stock as of June 1, 2024 and 198 shares as of June 2, 2024.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting stock transactions by a company director, indicating a neutral sentiment.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, which is a common occurrence for publicly traded companies. It provides transparency to investors regarding the actions of company leadership.

Stakeholder Impact

  • The disclosure of insider transactions provides transparency to shareholders.

Key Dates

DateDescription
June 1, 2021Reporting person was granted 893 (20 post-split) RSUs, vesting in three approximately equal annual installments beginning on June 1, 2022.
June 1, 2022First vesting date of RSUs granted on June 1, 2021.
June 2, 2023Reporting person was granted 3,571 (81 post-split) RSUs, vesting in full on the first anniversary of the date of grant.
March 5, 2024Aptevo Therapeutics effected a 1-for-44 reverse stock split.
June 1, 2024Director acquired 7 shares of common stock through RSU vesting.
June 2, 2024Director acquired 81 shares of common stock through RSU vesting.
June 3, 2024Date of the Form 4 filing.

Keywords

Aptevo Therapeutics, Grant Grady III, Form 4, SEC, Director, Stock, RSU, Reverse Stock Split

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.